A plasma membrane–associated form of the androgen receptor enhances nuclear androgen signaling in osteoblasts and prostate cancer cells
Science Signaling · 2024
DOI: 10.1126/scisignal.adi7861 ↗Kurz gefasst
Fachartikel in der Zeitschrift Science Signaling, 2024. Verfasst von Hema Kalyanaraman und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine, University of California, San Diego, La Jolla, CA 92093, USA. Hauptthemen laut MEDLINE: Androgens, Prostatic Neoplasms. Die Arbeit wurde bisher 17-mal zitiert (Crossref) und nennt 78 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NINDS NIH HHS, NIA NIH HHS, NIAMS NIH HHS.
Abstract (Originalsprache)
Androgen binding to the androgen receptor (AR) in the cytoplasm induces the AR to translocate to the nucleus, where it regulates the expression of target genes. Here, we found that androgens rapidly activated a plasma membrane–associated signaling node that enhanced nuclear AR functions. In murine primary osteoblasts, dihydrotestosterone (DHT) binding to a membrane-associated form of AR stimulated plasma membrane–associated protein kinase G type 2 (PKG2), leading to the activation of multiple kinases, including ERK. Phosphorylation of AR at Ser 515 by ERK increased the nuclear accumulation and binding of AR to the promoter of Ctnnb1 , which encodes the transcription factor β-catenin. In male mouse osteoblasts and human prostate cancer cells, DHT induced the expression of Ctnnb1 and CTNN1B , respectively, as well as β-catenin target genes, stimulating the proliferation, survival, and differentiation of osteoblasts and the proliferation of prostate cancer cells in a PKG2-dependent fashion. Because β-catenin is a master regulator of skeletal homeostasis, these results explain the reported male-specific osteoporotic phenotype of mice lacking PKG2 in osteoblasts and imply that PKG2-dependent AR signaling is essential for maintaining bone mass in vivo. Our results suggest that widely used pharmacological PKG activators, such as sildenafil, could be beneficial for male and estrogen-deficient female patients with osteoporosis but detrimental in patients with prostate cancer.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Medicine, University of California, San Diego, La Jolla, CA 92093, USA.
ORCID-Profile: Hema Kalyanaraman, Darren E Casteel, Shyamsundar Pal China, Gerry R Boss, Renate B Pilz
Förderung
- NINDS NIH HHS
- NIA NIH HHS
- NIAMS NIH HHS
Zitieren
APA
Kalyanaraman, H., Casteel, D. E., China, S. P., Zhuang, S., Boss, G. R., & Pilz, R. B. (2024). A plasma membrane–associated form of the androgen receptor enhances nuclear androgen signaling in osteoblasts and prostate cancer cells. Science Signaling. https://doi.org/10.1126/scisignal.adi7861
Vancouver
Kalyanaraman H, Casteel DE, China SP, Zhuang S, Boss GR, Pilz RB. A plasma membrane–associated form of the androgen receptor enhances nuclear androgen signaling in osteoblasts and prostate cancer cells. Science Signaling. 2024. doi:10.1126/scisignal.adi7861
BibTeX
@article{Kalyanaraman2024,
author = {Kalyanaraman, Hema and Casteel, Darren E and China, Shyamsundar Pal and Zhuang, Shunhui and Boss, Gerry R and Pilz, Renate B},
title = {A plasma membrane–associated form of the androgen receptor enhances nuclear androgen signaling in osteoblasts and prostate cancer cells},
journal = {Science Signaling},
year = {2024},
doi = {10.1126/scisignal.adi7861}
}
EUVIMED